We aim to establish an independent Data Monitoring Committee (DMC) comprising an independent chair and two other independent members, to monitor accumulating data during the course of the trial. All personnel will have undertaken the mandatory Good Clinical Practice (GCP) training.
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.